SEC Filing Summary: MRI Interventions, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on March 18, 2015. The report discloses a letter dated March 18, 2015, from Frank Grillo, Chief Executive Officer, to the Company's stockholders. The filing is made pursuant to Item 7.01 (Regulation FD Disclosure) to ensure fair disclosure of material non-public information.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a disclosure vehicle for a CEO letter rather than a financial statement.
Material Changes
No material financial changes or operational metrics are detailed in the text of this filing. The primary event reported is the issuance of the CEO's letter to stockholders.
Guidance, Outlook, and Risks
The filing states that the information contained in the attached Exhibit 99.1 (the CEO letter) is summary information intended to be considered in the context of other SEC filings and public announcements. The Company explicitly undertakes no duty or obligation to publicly update or revise the information contained in this report, though it may do so at management's discretion. The filing notes that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Key Facts for Investor Verification
- Verify the full content of the CEO letter (Exhibit 99.1) posted on the Company's "Investors" website, as the 8-K only references its existence.
- Confirm that the information in the letter is consistent with the Company's most recent 10-K or 10-Q filings, as the 8-K states the letter is summary information.
- Note that the Company has disclaimed any obligation to update the information provided in this specific filing.
- Identify the registrant as MRI Interventions, Inc., noting the discrepancy with the request metadata which listed "Clearpoint Neuro, Inc."